Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Canadian recommendations for the treatment of glioblastoma multiforme.
Mason WP, Maestro RD, Eisenstat D, Forsyth P, Fulton D, Laperrière N, Macdonald D, Perry J, Thiessen B; Canadian GBM Recommendations Committee. Mason WP, et al. Curr Oncol. 2007 Jun;14(3):110-7. doi: 10.3747/co.2007.119. Curr Oncol. 2007. PMID: 17593983 Free PMC article.
Phase II study of PX-866 in recurrent glioblastoma.
Pitz MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR, Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS, Kamel-Reid S, Banerji S, Tu D, Powers J, Hausman DF, Mason WP. Pitz MW, et al. Among authors: mason wp. Neuro Oncol. 2015 Sep;17(9):1270-4. doi: 10.1093/neuonc/nou365. Epub 2015 Jan 20. Neuro Oncol. 2015. PMID: 25605819 Free PMC article. Clinical Trial.
Radiation plus Temozolomide in Patients with Glioblastoma.
Perry JR, Laperriere N, Mason WP. Perry JR, et al. Among authors: mason wp. N Engl J Med. 2017 Jun 1;376(22):2197. doi: 10.1056/NEJMc1704726. N Engl J Med. 2017. PMID: 28564572 No abstract available.
A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study.
Mason WP, Macneil M, Kavan P, Easaw J, Macdonald D, Thiessen B, Urva S, Lwin Z, McIntosh L, Eisenhauer E. Mason WP, et al. Invest New Drugs. 2012 Dec;30(6):2344-51. doi: 10.1007/s10637-011-9775-5. Epub 2011 Dec 9. Invest New Drugs. 2012. PMID: 22160854 Clinical Trial.
Glioblastoma management in the temozolomide era: have we improved outcome?
Lwin Z, MacFadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, Menard C, Laperriere N, Mason WP. Lwin Z, et al. Among authors: mason wp. J Neurooncol. 2013 Nov;115(2):303-10. doi: 10.1007/s11060-013-1230-3. Epub 2013 Aug 25. J Neurooncol. 2013. PMID: 23979682
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.
Weller M, Gorlia T, Cairncross JG, van den Bent MJ, Mason W, Belanger K, Brandes AA, Bogdahn U, Macdonald DR, Forsyth P, Rossetti AO, Lacombe D, Mirimanoff RO, Vecht CJ, Stupp R. Weller M, et al. Neurology. 2011 Sep 20;77(12):1156-64. doi: 10.1212/WNL.0b013e31822f02e1. Epub 2011 Aug 31. Neurology. 2011. PMID: 21880994 Free PMC article. Clinical Trial.
163 results